Holen Sie sich die Stockscreener-App
86.54
0.46%
-0.40
Handel nachbörslich:
86.60
0.06
+0.07%
Schlusskurs vom Vortag:
$86.94
Offen:
$86.03
24-Stunden-Volumen:
193.43K
Relative Volume:
1.05
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.46%
1M Leistung:
-1.03%
6M Leistung:
-5.85%
1J Leistung:
+8.84%
1-Tages-Spanne:
$85.97
$87.24
1-Wochen-Bereich:
$85.97
$88.95
52-Wochen-Spanne:
$79.95
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
86.54 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.28 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
591.15 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
593.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
242.75 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
518.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
PPH Is a Pertinent Healthcare Idea for 2025 - ETF Trends
Broad Market Gains Shape Moat Strategies for 2025 - VanEck
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Bank of Montreal Can Grows Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The Inflation Reduction Act: A Green Catalyst - VanEck
Winners And Losers: Post-Election Options Analysis - Barchart
Big Pharma earnings season in spotlight amid positive sentiment - MSN
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? - MSN
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume – Time to Buy? - Defense World
US Bancorp DE Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The U.S. Shakes Up Global Pharma Supply Chains - Seeking Alpha
Trading The Shit Show: November 2024 Market Review - substack.com
AbbVie shares slip after schizophrenia drug trial misses primary endpoint - MSN
Health Care Roundup: Market Talk - MSN
RAPT scraps zelnecirnon program, stock plunges 44% - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
JPMorgan BetaBuilders U.S. Treasury Bond 20+ Year ETF declares monthly distribution of $0.3949 - MSN
Invesco BulletShares 2028 Municipal Bond ETF declares monthly distribution of $0.0567 - MSN
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
Stocks And ETFs In Focus As Americans Head To Polls - Barchart
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
From Gold to Digital Gold: VanEck's Journey with Crypto - VanEck
Vontobel Holding Ltd. Cuts Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
BUZZ Investing: Fed’s 50 bps Rate Cut Market Rally - VanEck
Default Risk Eases For Most U.S. Market Sectors In Q3 2024 - Seeking Alpha
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - Yahoo Finance
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Yahoo Finance
The Growing Role of AI in Nuclear Energy Investing - VanEck
Diversified Exposure To The Weight Loss Drug Market - Seeking Alpha
Teva Pharmaceutical hits a new 52-week high - MSN
Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie - MSN
Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules - MSN
Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH (NASDAQ:PPH) - Seeking Alpha
DBK Financial Counsel LLC Buys 142 Shares of Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV) - Defense World
Northwestern Mutual Wealth Management Co. Raises Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
General Electric (NYSE:GE) Shares Sold by B. Riley Wealth Advisors Inc. - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stock Holdings Increased by Renaissance Technologies LLC - Defense World
Healthcare ETFs Starting to Look Healthy - ETFdb.com
ProShares UltraShort Russell2000 (NYSEARCA:TWM) Shares Cross Below 50 Day Moving Average of $9.88 - Defense World
JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) Shares Acquired by Element Pointe Advisors LLC - Defense World
CLOBVanEck AA-BB CLO ETF | Holdings & Performance - VanEck
Three Forces Powering the Nuclear Energy Surge - VanEck
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Beck Capital Management LLC - Defense World
DoubleLine’s Jeffrey Gundlach on the Fed, Gold and Private Credit - ETF Trends
Virtu Financial LLC Acquires New Position in Global X Uranium ETF (NYSEARCA:URA) - Defense World
Axxcess Wealth Management LLC Reduces Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Telecom Argentina (NYSE:TEO) Downgraded by Scotiabank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase - Defense World
VanEck Mid-September 2024 Bitcoin ChainCheck: 1-Year Review Edition - VanEck
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.17%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):